LANSTROVE Trademark

Trademark Overview

On Thursday, February 8, 2007, a trademark application was filed for LANSTROVE with the United States Patent and Trademark Office. The USPTO has given the LANSTROVE trademark a serial number of 77103077. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 13, 2010. This trademark is owned by Amgen Inc.. The LANSTROVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith
lanstrove

General Information

Serial Number77103077
Word MarkLANSTROVE
Filing DateThursday, February 8, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 13, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 13, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, December 13, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 13, 2010ABANDONMENT - NO USE STATEMENT FILED
Friday, April 23, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 22, 2010EXTENSION 5 GRANTED
Monday, April 19, 2010EXTENSION 5 FILED
Monday, April 19, 2010TEAS EXTENSION RECEIVED
Thursday, October 29, 2009EXTENSION 4 GRANTED
Tuesday, October 27, 2009EXTENSION 4 FILED
Tuesday, October 27, 2009TEAS EXTENSION RECEIVED
Wednesday, April 22, 2009EXTENSION 3 GRANTED
Tuesday, April 21, 2009EXTENSION 3 FILED
Tuesday, April 21, 2009TEAS EXTENSION RECEIVED
Monday, September 29, 2008EXTENSION 2 GRANTED
Friday, September 26, 2008EXTENSION 2 FILED
Monday, September 29, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 26, 2008TEAS EXTENSION RECEIVED
Wednesday, April 23, 2008EXTENSION 1 GRANTED
Wednesday, April 16, 2008EXTENSION 1 FILED
Wednesday, April 16, 2008TEAS EXTENSION RECEIVED
Tuesday, November 13, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2007NOTICE OF PUBLICATION
Tuesday, July 17, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 17, 2007ASSIGNED TO LIE
Tuesday, June 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 12, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 12, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 12, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 12, 2007ASSIGNED TO EXAMINER
Friday, March 30, 2007NON-FINAL ACTION E-MAILED
Friday, March 30, 2007NON-FINAL ACTION WRITTEN
Thursday, March 29, 2007ASSIGNED TO EXAMINER
Tuesday, February 13, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

lanstrove disorders complications associated therewith diseases metabolic preparations treatment oncological pharmaceutical